Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND CDX2, CDX3, 1045, ENSG00000165556, Q99626 AND Treatment
102 results:

  • 1. Renin-Angiotensin Inhibitor, Captopril, Attenuates Growth of Patient-Derived colorectal Liver Metastasis Organoids.
    Riddiough GE; Fifis T; Muralidharan V; Christophi C; Tran BM; Perini MV; Vincan E
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542253
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Multivariate Prognostic Models for Patients with Stages I and Ii Colon Carcinoma: a Strobe-Compliant Retrospective Cohort Study.
    Oñate-Ocaña LF; Herrera-Goepfert R; Avilés-Salas A; Cortés CC; González-Trejo S; Carrillo JF; Ruiz-García E; Ochoa-Carrillo FJ; Aiello-Crocifoglio V; García-Cuellar CM
    Rev Invest Clin; 2023; 75(5):259-271. PubMed ID: 37918013
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The prognostic potential of cdx2 in colorectal cancer: Harmonizing biology and clinical practice.
    Badia-Ramentol J; Gimeno-Valiente F; Duréndez E; Martínez-Ciarpaglini C; Linares J; Iglesias M; Cervantes A; Calon A; Tarazona N
    Cancer Treat Rev; 2023 Dec; 121():102643. PubMed ID: 37871463
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. cdx2-positive cancer of Unknown Primary With Upper-body Paralysis Was Dramatically Improved by colorectal cancer Chemotherapy.
    Akagi H; Tanaka Y; Wada K; Takahashi M; Yoshida K; Domoto H
    Anticancer Res; 2023 Jun; 43(6):2879-2884. PubMed ID: 37247890
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Molecular profiling of colorectal cancer in a genetically admixed Hispanic population.
    Montes-Rodríguez IM; Centeno-Girona H; Rivera-Lynch C; Rivera N; Cruz-Correa M
    Cancer Med; 2023 May; 12(10):11686-11702. PubMed ID: 37039257
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. CDX-2 expression correlates with clinical outcomes in MSI-H metastatic colorectal cancer patients receiving immune checkpoint inhibitors.
    Ziranu P; Pretta A; Pozzari M; Maccioni A; Badiali M; Fanni D; Lai E; Donisi C; Persano M; Gerosa C; Puzzoni M; Bardanzellu F; Ambu R; Pusceddu V; Dubois M; Cerrone G; Migliari M; Murgia S; Spanu D; Pretta G; Aimola V; Balconi F; Murru S; Faa G; Scartozzi M
    Sci Rep; 2023 Mar; 13(1):4397. PubMed ID: 36928082
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Urachal carcinoma: The journey so far and the road ahead.
    Kumar R; Harilal S; Abdelgawad MA; Ghoneim MM; Kumar A; Mathew B
    Pathol Res Pract; 2023 Mar; 243():154379. PubMed ID: 36821941
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Fistula-Associated Anal Adenocarcinoma: A 20-Year Single-Center Experience.
    Harpain F; Dawoud C; Wimmer K; Schlager L; Kirchnawy S; Rizk D; Girgis K; Mittermair E; Oberndorfer F; Wöran K; Riss S; Stift A; Stift J
    Ann Surg Oncol; 2023 Jun; 30(6):3517-3527. PubMed ID: 36757514
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The first comprehensive genomic characterization of rectal squamous cell carcinoma.
    Astaras C; De Vito C; Chaskar P; Bornand A; Khanfir K; Sciarra A; Letovanec I; Corro C; Dietrich PY; Tsantoulis P; Koessler T
    J Gastroenterol; 2023 Feb; 58(2):125-134. PubMed ID: 36357817
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. colorectal cancer organoid models uncover oxaliplatin-resistant mechanisms at single cell resolution.
    Chen G; Gong T; Wang Z; Wang Z; Lin X; Chen S; Sun C; Zhao W; Kong Y; Ai H; Yang H; Liu Y; Wu F; Kang J; Zhao S; Xiao X; Sun J; He A; Li Z
    Cell Oncol (Dordr); 2022 Dec; 45(6):1155-1167. PubMed ID: 36136268
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Phase Ia/b, Open-Label, Multicenter Study of AZD4635 (an Adenosine A2A Receptor Antagonist) as Monotherapy or Combined with Durvalumab, in Patients with Solid Tumors.
    Lim EA; Bendell JC; Falchook GS; Bauer TM; Drake CG; Choe JH; George DJ; Karlix JL; Ulahannan S; Sachsenmeier KF; Russell DL; Moorthy G; Sidders BS; Pilling EA; Chen H; Hattersley MM; Das M; Kumar R; Pouliot GP; Patel MR
    Clin Cancer Res; 2022 Nov; 28(22):4871-4884. PubMed ID: 36044531
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Oligometastatic deposits of prostate cancer found within the sigmoid pericolic fat that was resected for colonic adenocarcinoma: a case report.
    Naumann DN; Hejmadi RK; Richardson JJR
    J Med Case Rep; 2022 Jun; 16(1):221. PubMed ID: 35659714
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Activation of FXR and inhibition of EZH2 synergistically inhibit colorectal cancer through cooperatively accelerating FXR nuclear location and upregulating cdx2 expression.
    Yu J; Yang K; Zheng J; Zhao P; Xia J; Sun X; Zhao W
    Cell Death Dis; 2022 Apr; 13(4):388. PubMed ID: 35449124
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Progress in pulmonary enteric adenocarcinoma].
    Zuo Y; Bai H; Ying JM; Wang J
    Zhonghua Zhong Liu Za Zhi; 2022 Apr; 44(4):321-325. PubMed ID: 35448919
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Current Perspectives on the Importance of Pathological Features in Prognostication and Guidance of Adjuvant Chemotherapy in Colon cancer.
    Chen K; Wang H; Collins G; Hollands E; Law IYJ; Toh JWT
    Curr Oncol; 2022 Feb; 29(3):1370-1389. PubMed ID: 35323316
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. cdx2 Biomarker Testing and Adjuvant Therapy for Stage II Colon cancer: An Exploratory Cost-Effectiveness Analysis.
    Alarid-Escudero F; Schrag D; Kuntz KM
    Value Health; 2022 Mar; 25(3):409-418. PubMed ID: 35227453
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Pathological Features and Prognostication in colorectal cancer.
    Chen K; Collins G; Wang H; Toh JWT
    Curr Oncol; 2021 Dec; 28(6):5356-5383. PubMed ID: 34940086
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The dual role of microRNA-9 in gastrointestinal cancers: oncomiR or tumor suppressor?
    Bahrami A; Jafari A; Ferns GA
    Biomed Pharmacother; 2022 Jan; 145():112394. PubMed ID: 34781141
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [Clinicopathological analysis of lung metastatic tumor].
    Lou N; Niu YR; Yang F; Lu ZH
    Zhonghua Bing Li Xue Za Zhi; 2021 Sep; 50(9):1039-1044. PubMed ID: 34496496
    [No Abstract]    [Full Text] [Related]  

  • 20. Combination of Sulindac and Bexarotene for Prevention of Intestinal Carcinogenesis in Familial Adenomatous Polyposis.
    Bowen CM; Walter L; Borras E; Wu W; Ozcan Z; Chang K; Bommi PV; Taggart MW; Thirumurthi S; Lynch PM; Reyes-Uribe L; Scheet PA; Sinha KM; Vilar E
    Cancer Prev Res (Phila); 2021 Sep; 14(9):851-862. PubMed ID: 34266857
    [TBL] [Abstract] [Full Text] [Related]  


    of 6.